News

Twinlab Consolidation Corp. acquires Twinlab Corp. in strategic, employee-led buyout

BY Michael Johnsen

NEW YORK — Twinlab Consolidation Corp. on Monday announced it has acquired Twinlab Corp. in a strategic, employee-led buyout. 
 
“In a fragmented industry, it is fundamentally difficult to influence outcomes and shepherd change," stated Tom Tolworthy, TCC CEO. "This applies to everything from government regulation to standardized raw material quality to the simple consumer desire for safe and efficacious solutions for their health needs,” he said. “Steeped in the authenticity of natural, clean, organic, good-for-you health solutions, TCC aspires to serve the rapidly growing needs of the health-conscious consumer through proprietary manufacturing, efficacious health solutions built on science, and increased market penetration through focused customer-based distribution.”
 
According to the company, the buyout is designed to inject new life into an existing brand and create new opportunity through the expansion of distribution channels and increased manufacturing capacity. 
 
"Everything that happens in this industry starts with the 6,000 mom-and-pop health food stores," Tolworthy said. "They are the educators – the innovators – and they set the trends that everyone else economizes against. TCC not only wants to move along the curve of those trends, we plan to move the curve."
 
In addition to its namesake brand, Twinlab, established in 1968, TCC also manufactures and sells other brands including the Metabolife line of diet and energy products; Fuel line of sports supplement products; Alvita teas; and Trigosamine joint support products.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

FDA announces approval for Orbactiv

BY Ryan Chavis

SILVER SPRING, Md. — The Food and Drug Administration earlier this week announced approval for Orbactiv (oritavancin), an antibacterial drug used to treat patients with acute bacterial skin and skin structure infections. The drug is administered intravenously.

Orbactiv is the third new antibacterial drug approved by the FDA this year to treat ABSSSI. The agency previously announced approval for Dalvance and Sivextro.

“The approval of several new antibacterial drugs this year demonstrates that we are making progress in increasing the availability of treatment options for patients and physicians,” said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. “However, more work is needed in this area, and the FDA remains a committed partner to help promote the development of antibacterial drugs.”

Orbactiv is marketed by the Medicines Co.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

NACDS RxImpact hosts 82nd pharmacy tour in 2014

BY Antoinette Alexander

ALEXANDRIA, Va. — Several NACDS chain member companies have conducted Congressional pharmacy tours in recent weeks, bringing the total number of NACDS RxImpact in-district events to 82 for 2014.  

NACDS pharmacy tours are all about educating Congress about the value pharmacy provides and giving legislators and their staff members an inside view about what makes pharmacies such integral, accessible resources in communities.

Among the most recent in-district events, regional director for Rep. Michael McCaul, R-Texas, toured the H-E-B in Katy, Texas, on Aug. 5. The pharmacy team reported that the tour, which lasted over an hour, was "excellent." NACDS RxImpact hosted two additional in-district activities during the week, which brings the total number for 2014 to 82. Rep. Joaquin Castro, D-Texas, toured a San Antonio H-E-B and the district director for Rep. David Schweikert, R-Ariz., toured a Scottsdale, Ariz. Walgreens.

Additional Congressional pharmacy tours include — U.S. Rep. Chris Van Hollen, D-Md, toured a Westminster, Md. Giant; U.S. Rep. Henry Cuellar (pictured above), D-Texas, toured a Lavernia, Texas HEB Pharmacy and U.S. Rep. Lynne Jenkins, R-Kan., a member of the House Ways & Means Committee, met with Hy-Vee at the Jenkins' Topeka, Kan., District Office. Also, the district director for U.S. Rep. Steve Womack, R-Ark., toured a Rogers, Ark., Walmart, the district director for U.S. Rep. Matt Salmon, R-Ariz., toured a Gilbert, Ariz., Walmart, and the deputy district director for U.S. Rep. Steve Southerland, R-Fla., toured a Tallahassee, Fla., Walgreens.

The grassroots advocacy program also posted its 16th and 17th continuing education training sessions as part of the Tennessee Pharmacists Association Annual Meeting. The CE training programs in Tennessee educated pharmacists and students about the power of effective constituent communications to influence the policymaking process.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES